Skip to content

IONS history

Every recorded change to IONS's data, most recent first.

  1. CurrentNext earnings date moved to Feb 9, 2027; next earnings date is now an estimate; the company overview was rewritten; the investment thesis was rewritten; the listed risks were updated; the balance sheet was rewritten; checkpoint failed: Q3 2026 results: first quarter of the TRYNGOLZA sHTG launch; checkpoint moved to Feb 9, 2027: Full-year 2026 results and 2027 outlook; recent events were updated.
  2. Next earnings date moved to Nov 9, 2026; next earnings date is now confirmed; the investment thesis was rewritten; checkpoint moved to Nov 9, 2026: Q3 2026 results: first quarter of the TRYNGOLZA sHTG launch; recent events were updated.
  3. Next earnings date moved to Nov 4, 2026; the investment thesis was rewritten; the listed risks were updated; checkpoint passed: FDA decision on GSK's bepirovirsen in chronic hepatitis B; checkpoint moved to Nov 4, 2026: Q3 2026 results: first quarter of the TRYNGOLZA sHTG launch; recent events were updated.
  4. The investment thesis was rewritten; new checkpoint: EU decision on TRYNGOLZA in severe hypertriglyceridemia; recent events were updated.
  5. This company was added.